Topline Phase 4 Results for SNRI ReleasedTopline Phase 4 Results for SNRI Released

Results from a large phase 4 study shows efficacy for desvenlafaxine 50 mg/day and 100 mg/day doses compared with placebo for the treatment of adult major depression. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news